167 related articles for article (PubMed ID: 15637323)
1. Secondary prevention of recurrent stroke.
Hankey GJ
Stroke; 2005 Feb; 36(2):218-21. PubMed ID: 15637323
[No Abstract] [Full Text] [Related]
2. Prevention of stroke recurrence.
Gorelick PB
Int Psychogeriatr; 2003; 15 Suppl 1():167-71. PubMed ID: 16191235
[TBL] [Abstract][Full Text] [Related]
3. Stroke: advances in therapy.
Schellinger PD; Hacke W
Lancet Neurol; 2005 Jan; 4(1):2. PubMed ID: 15620844
[No Abstract] [Full Text] [Related]
4. Ischaemic stroke--prevention is better than cure.
Hankey GJ
J R Coll Physicians Edinb; 2010 Mar; 40(1):56-63. PubMed ID: 21125042
[No Abstract] [Full Text] [Related]
5. Antithrombotic drugs for the secondary prevention of ischemic stroke.
Nenci GG; Goracci S
Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
[TBL] [Abstract][Full Text] [Related]
6. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack.
Davis SM; Donnan GA
N Engl J Med; 2012 May; 366(20):1914-22. PubMed ID: 22591297
[No Abstract] [Full Text] [Related]
7. Antiplatelet agents for stroke prevention following transient ischemic attack.
Weinberger J
South Med J; 2008 Jan; 101(1):70-8. PubMed ID: 18176296
[TBL] [Abstract][Full Text] [Related]
8. [Antithrombotic drugs and stroke: clinical trials and unanswered questions].
Lavallée P
Therapie; 2006; 61(5):401-5. PubMed ID: 17243269
[TBL] [Abstract][Full Text] [Related]
9. Carotid stenting.
Roffi M; Yadav JS
Circulation; 2006 Jul; 114(1):e1-4. PubMed ID: 16818819
[No Abstract] [Full Text] [Related]
10. A critical review of aspirin in the secondary prevention of noncardioembolic ischaemic stroke.
Inzitari D; Piccardi B; Sarti C
Int J Stroke; 2010 Aug; 5(4):306-18. PubMed ID: 20636714
[TBL] [Abstract][Full Text] [Related]
11. Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)?
Olson J; Huntington J
J Fam Pract; 2001 Jul; 50(7):623. PubMed ID: 11485713
[No Abstract] [Full Text] [Related]
12. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
Cardiovasc J Afr; 2008; 19(3):165. PubMed ID: 18568182
[No Abstract] [Full Text] [Related]
13. The role of antithrombotics in secondary stroke prevention.
Lazzaro MA; Malhotra K; Mohammad YM
Semin Neurol; 2010 Nov; 30(5):492-500. PubMed ID: 21207341
[TBL] [Abstract][Full Text] [Related]
14. Comment on "variations in the pharmacological management of patients treated with carotid endarterectomy: a survey of European vascular surgeons".
Stone DH; Nolan BW
Eur J Vasc Endovasc Surg; 2010 Jun; 39(6):797-8; author reply 798. PubMed ID: 20399123
[No Abstract] [Full Text] [Related]
15. Digestion of the antiplatelets comparison of PRoFESS: 18-7=1?
Algra A
Stroke; 2009 May; 40(5):1932-5. PubMed ID: 19038908
[No Abstract] [Full Text] [Related]
16. "Super aspirin" cuts risks after multiple cardiac events.
Heart Advis; 2004 Apr; 7(4):2. PubMed ID: 15114978
[No Abstract] [Full Text] [Related]
17. [Stroke prevention].
Arnold M; Nedeltchev K; Lyrer P; Baumgartner RW
Ther Umsch; 2003 Sep; 60(9):521-6. PubMed ID: 14579620
[TBL] [Abstract][Full Text] [Related]
18. Secondary prevention of atherothrombotic or cryptogenic stroke.
Tai WA; Albers GW
Circulation; 2014 Jan; 129(4):527-31. PubMed ID: 24470474
[No Abstract] [Full Text] [Related]
19. [Patent foramen ovale and stroke].
Mono ML; Nedeltchev K
Fortschr Neurol Psychiatr; 2012 May; 80(5):288-99. PubMed ID: 22566139
[No Abstract] [Full Text] [Related]
20. Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?
Amarenco P; Donnan GA
Stroke; 2004 Nov; 35(11):2606-8. PubMed ID: 15472090
[No Abstract] [Full Text] [Related]
[Next] [New Search]
